Joshua-Miller in Doubt as Miller Fails Drug Test
By: Michael Kane
Anthony Joshua’s U.S debut against Jarrell “Big Baby” Miller has been thrown into doubt after Miller tested positive for a banned substance.
Matchroom Promotions supremo Eddie Hearn took to social media and announced that he had been informed by VADA of the positive test.
We have been informed by VADA that there has been an adverse finding in Jarrell Miller’s sample collected on March 20th, 2019. We are working with all relevant parties and will update with more details soon. AJ’s preparation continues for June 1st at MSG.
— Eddie Hearn (@EddieHearn) April 17, 2019
The test, taken on March 20th from a random urine sample, has come back positive with a substance called GW1516 which is a banned performance enhancing substance.
ESPN broke the news, with Miller’s co-promoter Dmitry Salita saying he awaits further information and Miller is still in training for his June 1st fight.
Miller (23-0-1, 20 KOs) had been reported to earn around $4.5 million for his fight against champion Anthony Joshua, it would appear his chance has been blown with the NYSAC unlikely to sanction the bout at Madison Square Gardens. A negative B sample and supporting evidence would be required for any chance of the fight going ahead.
If the bout is cancelled, as seems likely, its unclear who will step in to face Joshua. According to Eddie Hearn, Joshua will be fighting on June 1st.
The obvious choice would have been Dillian Whyte however he has turned down an offer to face Joshua at Wembley Stadium in April, unhappy with the terms of the deal so it would appear unlikely he would travel to the U.S to take on Joshua.
Joshua’s IBF mandatory challenger, Kubrat Pulev, has recently been suspended by the Californian State Athletic Commision after kissing a female reporter after their post fight interview. His disciplinary is scheduled for May 18th.
A more likely candidate could be Michael Hunter (16-1, 11 KOs), the former Olylmpic champion has only lost once against Oleksandr Usyk as a cruiserweight. Since moving to heavyweight he has won the vacant WBA International Heavyweight Title by beating Alexander Ustinov by TKO last November.
Hunter seems to be interested.
Call me Eddie. https://t.co/1ck4qYJA19
— Michael Hunter ll (@MichaelHunterII) April 17, 2019
Alvarez-Golovkin And The Drug Testing Story That Never Should Have Been
By Jake Donovan
Saul ‘Canelo’ Alvarez and Gennady Golovkin have developed one of the most contentious rivalries in the sport today—so much, that even random social media discussion has somehow become headline news.
The latest twist involving the best two middleweights in the world today once again revisits the drug testing subplot, with the validity of random testing provided somehow—and falsely—called into question.
Both boxers were subject to random drug testing as administered by Voluntary Anti-Doping Agency (VADA)—a Las Vegas-based company founded by Dr. Margaret Goodman, a longtime advocate for the safety and health of boxers—surrounding their rematch this past September in Las Vegas.
The same agency was involved in their first fight one year prior, with testing at the time serving as merely a footnote. The far greater focus was on their HBO Pay-Per-View headliner ending in a highly questionable split decision draw which many felt Golovkin deserved to win.
The two camps came to terms for an agreed-upon rematch, which was due to take place this past May. However, the drug testing angle became the major focal point after Alvarez was discovered to have failed two VADA-conducted tests, both showing trace amounts of the banned substance Clenbuterol.
Even while armed with the alibi of the substance being unknowingly digested through contaminated meat—an ongoing epidemic in Alvarez’ native Mexico—the ultimate decision rendered down by the Nevada State Athletic Commission was for the superstar athlete to serve a six-month suspension, while also issuing the reminder that all athletes are responsible for what goes into their bodies regardless of means of consumption.
Alvarez took the punishment, also agreeing to enroll in year-round VADA testing which began in May. The decision served as the first step toward rescheduling his rematch with Golovkin, with the two sides going beyond their internally-imposed deadline in ultimately coming to terms to once again meet in September.
With Alvarez already enrolled, VADA agreed to create a specific testing program for the rematch, with the September 15 fight night date serving as the closing period. Alvarez won a majority decision in a fight where most ringside observers felt a draw or a close Golovkin victory was the more appropriate call, but the outcome not as contentious as was the case one year prior.
Except to the Golovkin camp.
The loss ended his reign of 20 successful defenses (which includes five defenses of an “interim” title, which some historians dismiss), tying him with Bernard Hopkins, a stakeholder in Golden Boy Promotions, Alvarez’s promoter. The post-fight drug test which followed was also supposed to end the testing period as it pertained to this bout, although Alvarez was due to remain in the program as per his contracted agreement to year-round testing which runs through May 2019.
This somehow became a topic of discussion two months after the fact.
A random discussion on social media called to question whether or not Alvarez remained enrolled in VADA’s program without interruption. The inquiry came about after the agency welcomed to the program reigning secondary super middleweight titlist Rocky Fielding, who will face Alvarez on December 15 at Madison Square Garden in New York City.
The conversation took a bizarre turn when Tom Loeffler—managing director of 360 Promotions and the driving force behind Golovkin’s career—offered a response suggesting that post-fight testing was yet another angle in the rivalry in which their side was dealt the short straw.
“VADA scheduled a random test for GGG a week after the fight,” Loeffler stated on social media. “I made sure that Canelo was also going to be tested. Next day the random test was cancelled. Strange that it was scheduled then cancelled, maybe Canelo was already in [Mexico] eating steaks celebrating his ‘decision’.”
Not only was it the wrong setting for such a pointed remark but was entirely incorrect in its implication.
The eventually canceled test was initially scheduled by the Nevada State Athletic Commission, which has often contracted VADA for testing needs. However, the decision to test both fighters that far after the fight was not made by VADA, as Golovkin’s specific obligation to the program ended on fight night.
“Tom Loeffler’s tweets regarding Golovkin/Alvarez testing are not correct,” Goodman told BoxingInsider.com via email in response to the conversation. “VADA tested both fighters many times leading up to their rematch and post-fight. Mr. Alvarez remains in VADA’s year-round testing program and subject to testing.
“Golovkin’s program ended September 15, 2018. The commission initially requested that we arrange to test both fighters again. Since many fighters travel after an event, and as Golovkin was no longer in VADA we confirmed his whereabouts. However, soon after the confirmation, the commission changed their decision.”
The decision as well as Goodman’s take were both subsequently confirmed by Golovkin’s side while offering its best efforts to walk back such comments.
“It was not VADA that cancelled the test, apparently it was the Commission,” Loeffler confirmed to BoxingInsider.com via text. “I didn’t mean to disparage VADA in any way; I’m a firm believer in what they do and that they are the best testing we have to try to prevent any banned substance use. Their testing is what showed the two positive tests for Canelo for Clenbuterol and that wouldn’t have shown up had we not started early testing with VADA.
“They cancelled the test for GGG, not sure what they did with Canelo, I just figured both were cancelled, but that information would have to come from VADA or the commission. We have insisted on VADA testing for all of the GGG fights as well as (former World heavyweight champion Wladimir) Klitschko fights in Europe and Moscow, so we believe in their testing program being effective and complimenting the WBC clean boxing program.”
Golovkin remains on the hunt for a new platform to carry his next fight and beyond. The knockout artist from Kazakhstan was among the many boxers left without a network home after HBO—the premium cable giant whom has aired all but two of his bouts since his stateside debut in 2012—announced in September that it would no longer remain in the boxing business following their final forthcoming December 8 telecast (fittingly, presented by Loeffler’s 360 Promotions). Talks are ongoing with many top players, including the top brass at ESPN, Showtime and sports streaming service DAZN, the latter with whom Alvarez signed a record-breaking contract and on which he will debut in December.
There stands a chance that their paths will once again cross. Hopefully by then, the storylines will remain limited to their in-ring rivalry and not news items that never should have been news to begin with.
Wilder vs. Fury Drug Testing Status
By: Jake Donovan
While the promotion is in full bloom for the forthcoming December 1 heavyweight title clash between Deontay Wilder and Tyson Fury, the seeds for random drug testing protocol haven’t even been planted.
The clash of heavyweight titans—which will air live via Showtime Pay-Per-View from the Staples Center in Los Angeles, Calif.—has been at least seven weeks in the works, but those involved in the promotion have yet to file the necessary paperwork with Voluntary Anti-Doping Agency (VADA). The Nevada-based organization oversees all drug testing as part of the World Boxing Council’s (WBC) Clean Boxing Program, in which enrollment for all WBC-ranked boxers is supposed to be the standard.
“As of (Saturday), VADA has not received paperwork on Mr. Tyson Fury’s enrollment in the WBC’s CBP,” Dr. Margaret Goodman, founder and president of VADA told BoxingInsider.com over the weekend.
BoxingInsider.com contacted the WBC in mid-September on the subject when first learning of the development, but the inquiry was apparently lost in the shuffle as the Mexico-based sanctioning body was preparing for its annual convention which was held last week in Kiev, Ukraine.
Several topics were addressed during the convention, including a fresh batch of mandatory title fights and eliminators ordered which managed to generate the most headlines regarding anything WBC-related.
Not quite as pronounced was the concern of the WBC looking to subsidize the cost that comes with the Clean Boxing Program. Even with sponsorship, the sanctioning body is still coming out-of-pocket for a reported $75,000 per year on tests.
A question that wasn’t answered—neither in the seven weeks since Wilder (40-0, 39KOs) and Fury (27-0, 19KOs) publicly revealed their plans to collide later this year, nor in the four months since Fury first re-entered the WBC’s Top 15 heavyweight rankings—was when the unbeaten former heavyweight titlist from England would enroll in the program.
At least until they were finally cornered on the subject.
“Fury must enroll,” Mauricio Sulaiman, WBC president told BoxingInsider.com, through a statement from the WBC press office. “If he does not enroll, then the WBC cannot sanction the fight.”
Fury returned to the sport this past June, following a forced 31-month hiatus due to alcohol and drug abuse as well as mental health issues. The meltdown came on the heels of his career-best win, a 12-round landslide decision over Wladimir Klitschko in Nov. ’15 to win the lineal heavyweight championship, to which he still claims ownership.
The Irish Traveller never made a single defense, vacating one belt early when agreeing to a mandated rematch with Klithschko and then being stripped of all of his titles after the aforementioned sequel never came to pass. Fury twice postponed, first claiming an injury ahead of their planned July ’16 meet and then after getting popped by VADA for cocaine in his system during random testing ahead of their rescheduled fall ’16 battle.
Also in that period came an agreed-upon two year ban as issued by the United Kingdom Anti-Doping (UKAD), who claimed that Nandrolone was found in tests surrounding Fury’s win over Christian Hammer in Feb. ’15. The matter wasn’t discovered until later that year, but didn’t cause a delay in Fury’s title challenge versus Klitschko (other than Klitschko’s own four-week postponement due to an alleged injury sustained in training camp). Nor was the issue even readdressed until a hearing in June ’16, at which point UKAD charged Fury and his cousin, heavyweight contender Hughie Fury (who was popped for the same substance in March ’15) with presence of a prohibited substance.
Fury was finally cleared to fight in 2018, returning in June with a 4th round stoppage of Sefer Seferi. The victory was rewarded by the WBC with his being reinstated in their rankings, issued a #7 position in their heavyweight Top 15 pending his enrollment in their Clean Boxing Program. The organization has dropped several fighters for not agreeing to the program, but in the case of Fury merely kept moving the line in the sand.
Such concerns weren’t raised by any involved parties by the time he faced Francesco Pianeta this past August. Fury won a pedestrian 10-round decision, with the fight—largely forgettable on its own—overshadowed his post-fight in-ring “confrontation” with Wilder, who was ringside in Belfast to scout his then-potential future opponent.
The status went from potential to confirmed the moment Fury was declared the winner, as the two shared mostly playful insults during the on-air post-fight interview.
The fact that it has taken seven weeks (and counting) for event handlers to file the necessary paperwork with VADA contradicts claims made by Fury of his enrollment status.
Perhaps more revealing was his spray-painted verbal response, naming every drug testing organization that came to mind.
“I’m actually enrolled in VADA and USADA,” Fury told a group of reporters during the Los Angeles leg of his three-city press tour to promote the December 1, in video filmed by BoxingInsider.com’s own Jeandra LeBeauf. “They have to know my whereabouts. I have to tell World Anti-Doping (Agency) where I am within an hour every day.”
It also comes in stark contrast to Wilder’s longtime demands for his bouts to portray the image of a clean sport.
From the time he outpointed Bermane Stiverne to win the WBC strap in Jan. ’15, Wilder has been a vocal advocate for stricter drug testing protocol. Each of his seven title defenses have come with random testing existing far beyond the limited means in which most commission tests are conducted.
The unbeaten heavyweight from Alabama became something of a drug-testing jinx, with three of his scheduled challengers all busted by VADA for evidence of banned substances in their respective systems. Most notable among the lot was 2004 Olympic Gold medalist and former secondary titlist Alexander Povetkin coming up dirty for trace amounts of Meldonium, which ultimately killed their planned May ’16 title defense in Moscow, Russia.
Wilder would settle for a voluntary title defense, beating Chris Arreola that July in Birmingham, Alabama, less than an hour from his Tuscaloosa hometown. He’d return there for a Feb. ’17 title defense against Gerald Washington, who was brought in as a replacement for Andrzej Warwzyk, who was popped by VADA mere days after the fight was formally announced.
The one opponent who was caught but would get a second chance was Luis Ortiz, who attributed banned diuretics found in his system last September to prescription blood pressure medication. The then-unbeaten southpaw from Miami by way of Cuba was eventually cleared, but forced to sit out of their planned clash last November as punishment for failing to disclose the medication when he first filed paperwork with VADA.
Ortiz would get his chance this past March, pushing Wilder to the brink before eventually succumbing in the 10th round of their title fight thriller.
From there, Wilder has done his best to bring to light a clash with divisional rival and unbeaten, unified heavyweight titlist Anthony Joshua. Once it became clear that such a fight wouldn’t materialize in 2018—or if ever at all, the 6’7” heavyweight sought the next biggest event, which led to his team securing a deal with Fury.
What’s still left to do, is secure drug testing to ensure the biggest stateside heavyweight title fight this decade is, in fact, a clean event. Wilder continues to do his part, but that hardly covers all the bases.
“Mr. Wilder continues to be enrolled in the CBP,” Goodman confirmed to BoxingInsider.com, but with a kicker. “As yet, VADA has not been contacted by representatives of Mr. Wilder or Mr. Fury or by the WBC to test both fighters leading up to their December bout.”
With less than eight weeks to go before the opening bell, the clock is ticking for such testing to even serve its full purpose.
Bob Arum Bashes UFC For Drug Tests, Dismisses MMA Fans As Trump Supporters
Bob Arum Bashes UFC For Drug Tests, Dismisses MMA Fans As Trump Supporters
By: Sean Crose
Who knew Bob Arum was such a picture of virtue? For decades now, the man has stood atop – or near the top – of what has been known as the red light district of sports…boxing. Yet it was another combat sport that Arum took the time to bash recently – the Ultimate Fighting Championship, better known as the UFC. Truth be told, the mixed martial arts league has been hit hard recently with news that numerous of its top fighters have tested positive for drug use. Needless to say, Arum had choice words regarding the matter of drug testing:
“I don’t think,” he stated, “(it) is particularly necessary as far as fighters are concerned. Most fighters obey the rules. It’s probably more necessary in MMA because they appear to be unconcerned with the testing.” Ouch. Yet the man wasn’t done. Not by a long shot. “What the hell?” he asked rhetorically. “As long as the tests come out after the fight, right? Everybody’s collecting money. Just saying. just saying.” Just saying indeed.
Arum then moved on to addressing the recent sale of the UFC, for a reported four billion – that’s billion – dollars. “Good luck to them,” he stated. “And for some reason they can buy off lobbyists so they’re not subject to the Muhammad Ali Act like promoters are in boxing – just saying.” That’s right, one of the biggest players in boxing has accused the UFC of some seriously shady tactics. By the way, word is Arum is interested in doing business with Al Haymon, who some suggest has also broken the Muhammad Ali act. Yet Arum had even more things to say, going so far as to attack UFC fans – many of whom happen to be die hard boxing fans, as well.
“In boxing,” Arum said, “we have a lot of minorities, African-American, Hispanics, Jewish promoters, people like that.” Never mind the fact that the UFC has fighters such as Jon Jones, the Diaz brothers and others, the guy had a point to make. “And,” he said, speaking of those in the boxing game, “pretty much, we’re Democrats. MMA people they’re for Trump. You ever look at an MMA audience? Of course they’re for Trump.”
Bob Arum the uniter.
UFC honcho Dana White, who himself has a strong boxing background, obviously had some things to add to the conversation. “Arum is the biggest dirtbag in all of sports,” he claimed. “I look forward to sticking around and continuing to kick his ass in every aspect of our business.” With all that in mind, UFC fans await the rematch between Conor McGregor, who was recently interested in boxing Floyd Mayweather, and Nate Diaz, who has helped train Andre Ward as a sparring partner. Clearly those two men don’t seem to have a problem with boxing and MMA coexisting. Then again, they aren’t Bob Arum. McGregor and Diaz have mouths on them, to be sure, but neither can stir the pot quite the way Mr. Arum does.
Then again, few can.